5-55322388-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015360.5(MTREX):c.196G>T(p.Val66Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000348 in 1,608,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V66I) has been classified as Uncertain significance.
Frequency
Consequence
NM_015360.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152162Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249196Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134770
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1456274Hom.: 0 Cov.: 28 AF XY: 0.0000152 AC XY: 11AN XY: 724716
GnomAD4 genome AF: 0.000210 AC: 32AN: 152162Hom.: 0 Cov.: 31 AF XY: 0.000215 AC XY: 16AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.196G>T (p.V66L) alteration is located in exon 2 (coding exon 2) of the SKIV2L2 gene. This alteration results from a G to T substitution at nucleotide position 196, causing the valine (V) at amino acid position 66 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at